Sep 2026· STAR Protocols· Vol 7· 0 citations· 31 references
Medicine
TL;DR
Semdock is presented, an extension of the original workflow that enables the preparation of docking-ready ligands from raw SDF, SMILES, and CSV datasets through an automated ligand preparation procedure and implements ligand-wise CPU-parallel docking.
Abstract
Summary Virtual screening of chemical libraries has long been a cornerstone for identifying candidate bioactive compounds. Recently, many tools have been developed to make virtual screening more accessible. Among them, the jamdock-suite provides an automated and user-friendly workflow that encompasses the entire process from library generation to docking evaluation. However, its library generation is restricted to the ZINC database and cannot process user-supplied chemical datasets. Here, we present semdock, an extension of the original workflow that enables the preparation of docking-ready ligands from raw SDF, SMILES, and CSV datasets through an automated ligand preparation procedure. The workflow was validated using 3,230 FDA-approved compounds and multiple protein targets. We also implemented ligand-wise CPU-parallel docking, reducing runtime by approximately 30% compared with conventional multithreaded execution. Evaluation across multiple protein targets confirmed that the extended workflow preserves the utility of the original framework while expanding its use to diverse public and user-defined datasets.
FlexAutoDock is an automated cloud-based molecular docking platform that provides a unified environment for protein-ligand docking and large-scale virtual screening, providing researchers with an accessible computational resource for accelerating early-stage drug discovery.
Md. Feroj Ahmed, M. Faysal, Khalid Muntasir Sawad et al.· bioRxiv· 0 citations
MolDockLab addresses the challenge of structure-based virtual screening with an automated, data-driven framework that optimizes SBVS workflows for a protein target, balancing predictive performance and computational efficiency.
Hamza Agha, Y. Ibrahim, Michael Backenköhler et al.· npj Drug Discovery· 0 citations
AdaptiveFlow enables drug discovery at unprecedented scale and supports the development of AI-driven methods, and identifies nanomolar inhibitors of two disease-relevant targets, ferroptosis suppressor protein 1 and poly(ADP-ribose) polymerase 1.
Domiziana Cecchini, AkshatKumar Nigam, Ming Tang et al.· Nature Biotechnology· 1 citation
Virtual screening remains a critical step in structure-based drug design, yet variability in docking algorithms and scoring functions often limits its reliability. To address this challenge, we introduce DockM8, an open-source platform for consensus virtual screening that integrates pocket detection, ligand preparation...
Antoine Lacour, Hamza Agha, Anna K. H. Hirsch et al.· Journal of Cheminformatics· 4 citations
AI/ML-based tools for generative and predictive modeling have become important contributors to small molecule drug discovery, enabling virtual compound design and ADME profiling prior to synthesis. Alongside these methods, simpler nonlearned strategies based on direct SMILES manipulation remain useful, particularly f...
K. Cusack, Jake M. Aquilina· ACS Medicinal Chemistry Lett...· 0 citations
This study compares four active-learning virtual screening workflows and suggests that combining active learning with SILCS provides a computationally efficient, membrane-aware approach for screening compounds at transmembrane binding sites.
Joseph Chung, Aashish Bhatt, Jacob Ede Levine et al.· Journal of Computer-Aided Mo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.